Recombinant CD37 (Naratuximab Biosimilar) antibody

Catalog No. ABIN7093065

This Mouse Chimeric antibody specifically detects CD37 (Naratuximab Biosimilar) in FACS. It exhibits reactivity toward Human.

Quick Overview for Recombinant CD37 (Naratuximab Biosimilar) antibody (ABIN7093065)

Target: CD37 (Naratuximab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Mouse

Clonality: Chimeric

Conjugate: This CD37 (Naratuximab Biosimilar) antibody is un-conjugated

Application: Flow Cytometry (FACS)

Grade: Research Grade

Product Details anti-CD37 (Naratuximab Biosimilar) Antibody

Purpose: Anti-CD37 (naratuximab biosimilar) mAb

Characteristics: IMGN-529, IMGN529, K7153A-SMCC-DM1

Purification: Purified from cell culture supernatant by affinity chromatography

Isotype: IgG1

Application Details

Application Notes: Flow Cyt 1:100

Comment:

Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.

Restrictions: For Research Use only

Handling

Format: Lyophilized

Reconstitution: Reconstitute with deionized water

Buffer: Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8 % trehalose is added as protectants before lyophilization.

Storage: -20 °C,-80 °C

Storage Comment: Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature.

Expiry Date: 12 months

Target Details for CD37 (Naratuximab Biosimilar)

Target: CD37 (Naratuximab Biosimilar)

Target Type: Biosimilar

Background: Synonyms: CD37, TSPAN26, Tspan-26

Gene ID: 951

UniProt: P11049